Anonymous ID: 56d437 Aug. 3, 2020, 2:05 p.m. No.10172118   🗄️.is 🔗kun

>>10172030

✅Chloroquine is a potent inhibitor of SARS coronavirus infection and spread https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1232869/

 

✅Early Hydroxychloroquine Is Associated with an Increase of Survival in COVID-19 Patients: An Observational Study , https://www.preprints.org/manuscript/202005.0057/v1

 

✅Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France https://www.sciencedirect.com/science/article/pii/S1477893920302179 , http://archive.is/VEdFi

 

Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity. https://www.ncbi.nlm.nih.gov/pubmed/15320751

 

Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689966/

 

✅Chloroquine Is a Zinc Ionophore https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182877/

 

Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001837/ , Drug Des Devel Ther. 2018; 12: 1685–1695, Published online 2018 Jun 11. doi: 10.2147/DDDT.S166893

 

https://pubmed.ncbi.nlm.nih.gov/16115318/

 

Chloroquine Is a Potent Inhibitor of SARS Coronavirus Infection and Spread

 

Here's the new study incoming:

 

https://www.nih.gov/news-events/news-releases/nih-begins-clinical-trial-hydroxychloroquine-azithromycin-treat-covid-19

 

NIH begins clinical trial of hydroxychloroquine and azithromycin to treat COVID-19

 

To keep track of the study, look here:

 

https://clinicaltrials.gov/ct2/show/NCT04358068

 

Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19

 

Collaborator: Teva Pharmaceuticals Industries LTD

 

https://www.ncbi.nlm.nih.gov/pubmed/16115318

 

and

 

https://www.ncbi.nlm.nih.gov/pubmed/15351731

 

Hydroxychloroquine can be prescribed to adults and children of all ages. It can also be safely taken by pregnant women and nursing mothers.

 

https://www.cdc.gov/malaria/resources/pdf/fsp/drugs/hydroxychloroquine.pdf

 

as anti cancer agent

 

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718030/

 

https://archive.is/kQq0o

 

google doc detailed summary

 

https://docs.google.com/document/d/1545C_dJWMIAgqeLEsfo2U8Kq5WprDuARXrJl6N1aDjY/preview

 

doctor vid

 

https://gofile.io/d/0Y3zQu

 

blood lipids https://www.hindawi.com/journals/jdr/2020/5214751/

 

https://pubmed.ncbi.nlm.nih.gov/?term=hydroxychloroquine

Anonymous ID: 56d437 Aug. 3, 2020, 2:05 p.m. No.10172120   🗄️.is 🔗kun

>>10172030

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156117/

 

✅Chloroquine is a potent inhibitor of SARS coronavirus infection and spread https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1232869/

 

✅Early Hydroxychloroquine Is Associated with an Increase of Survival in COVID-19 Patients: An Observational Study , https://www.preprints.org/manuscript/202005.0057/v1

 

✅Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France https://www.sciencedirect.com/science/article/pii/S1477893920302179 , http://archive.is/VEdFi

Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity. https://www.ncbi.nlm.nih.gov/pubmed/15320751

Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689966/

 

✅Chloroquine Is a Zinc Ionophore https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182877/

Chloroquine and hydroxychloroquine are associated with reduced cardiovascular risk: a systematic review and meta-analysis https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001837/ , Drug Des Devel Ther. 2018; 12: 1685–1695, Published online 2018 Jun 11. doi: 10.2147/DDDT.S166893

 

https://pubmed.ncbi.nlm.nih.gov/16115318/

Chloroquine Is a Potent Inhibitor of SARS Coronavirus Infection and Spread

 

Here's the new study incoming:

https://www.nih.gov/news-events/news-releases/nih-begins-clinical-trial-hydroxychloroquine-azithromycin-treat-covid-19

NIH begins clinical trial of hydroxychloroquine and azithromycin to treat COVID-19

 

To keep track of the study, look here:

https://clinicaltrials.gov/ct2/show/NCT04358068

 

Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19

Collaborator: Teva Pharmaceuticals Industries LTD

https://www.ncbi.nlm.nih.gov/pubmed/16115318

and

https://www.ncbi.nlm.nih.gov/pubmed/15351731

 

Hydroxychloroquine can be prescribed to adults and children of all ages. It can also be safely taken by pregnant women and nursing mothers.

 

https://www.cdc.gov/malaria/resources/pdf/fsp/drugs/hydroxychloroquine.pdf

Early Hydroxychloroquine Is Associated with an Increase of Survival in COVID-19 Patients: An Observational Study

https://www.preprints.org/manuscript/202005.0057/v1

 

Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France

https://www.sciencedirect.com/science/article/pii/S1477893920302179

http://archive.is/VEdFi

 

Chloroquine and hydroxychloroquine as inhibitors of human immunodeficiency virus (HIV-1) activity.

https://www.ncbi.nlm.nih.gov/pubmed/15320751

Hydroxychloroquine Improves Obesity-Associated Insulin Resistance and Hepatic Steatosis by Regulating Lipid Metabolism

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689966/

 

HCQ for MS (multiple sclerosis):

Minocycline and Hydroxychloroquine combined

Minocycline and hydroxychloroquine combined are candidate treatments for progressive MS.

https://www.ncbi.nlm.nih.gov/pubmed/28857721

 

'''Open-label, Single-center, Single-arm Futility Trial Evaluating Oral Hydroxychloroquine 200mg BID for Reducing Progression of Disability in Patients With Primary Progressive Multiple Sclerosis (PPMS)

Hydroxychloroquine in Primary Progressive Multiple Sclerosis'''

https://ichgcp.net/clinical-trials-registry/NCT02913157

Other:

https://clinicaltrials.gov/ct2/show/NCT02913157

 

Effectiveness of Chloroquine and Hydroxychloroquine in Treating Selected Patients With Sarcoidosis With Neurological Involvement

https://pubmed.ncbi.nlm.nih.gov/9740120/

 

Use of hydroxychloroquine for treatment of graft-versus-host disease

https://patents.google.com/patent/EP0650727A1/en

 

HCQ Studies

https://docs.google.com/document/d/1545C_dJWMIAgqeLEsfo2U8Kq5WprDuARXrJl6N1aDjY/edit

https://www.veteranstoday.com/2020/05/24/wuhangate-9-hiv-inserted-in-sars-chimeric-virus-in-2007-pics-thanks-to-australian-eu-commission-funds/

 

Indomethacin Has a Potent Antiviral Activity Against SARS Coronavirus

https://pubmed.ncbi.nlm.nih.gov/17302372/

https://archive.is/E3DQD

 

Breakthrough: Chloroquine Phosphate Has Shown Apparent Efficacy in Treatment of COVID-19 Associated Pneumonia in Clinical Studies

https://pubmed.ncbi.nlm.nih.gov/32074550/

https://archive.is/YztZs